Table 1 Patients’ Characteristics
From: Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro
Patients recruited | 34 | |
|---|---|---|
Median age (years) | 65 (range, 30–79) | |
One-year disease-specific survival | 73.5% | |
Gender | Male | 28 (83%) |
Female | 6 (17%) | |
Histology | Adenocarcinoma | 28 (76%) |
Squamous cell carcinoma | 6 (24%) | |
Tumour depth (T-stage) | T1 | 8 (24%) |
T2 | 3 (9%) | |
T3 | 23 (67%) | |
Nodal involvement | No (N0) | 15 (44%) |
Yes (N1) | 19 (56%) | |
Tumour differentiation | Moderate | 25 (74%) |
Poor | 9 (26%) | |
Vascular invasion | No | 21(62%) |
Yes | 13 (38%) | |
Barrett’s Metaplasia | No | 13 (46%) |
Yes | 15 (54%) | |
Circumferential resection margin | Not involved | 23 (68%) |
Involved | 11 (32%) | |
Preoperative chemotherapy | No | 9 (26%) |
Yes | 25 (74%) | |